◆英語タイトル:Pivot Pharmaceuticals Inc (PVOTF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9397
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Pivot Pharmaceuticals Inc (Pivot Pharmaceuticals), formerly Neurokine Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of cannabinoid based neutraceutical and pharmaceutical products. The company’s major product offerings include capsules and tablets, bulk powder, stick packs, beverages, oral solutions, lotions, creams and gels, pet food additives. It develops various technologies for cannabinoids including Thrudermic transdermanl nanotechnology, Solmic micelle oral drug delivery technology, BiPhasix topical delivery technology, Ready to Infuse Cannabis technology and TriVair drug delivery technology. Pivot Pharmaceuticals also provides cannabidiol and tetrahydrocannabinol-based products. The company has operations in the US and Canada. Pivot Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.
Pivot Pharmaceuticals Inc (PVOTF) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pivot Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Pivot Pharma to Acquire BiPhasix Transdermal Drug Delivery Technology from Altum Pharma 11
Licensing Agreements 12
Pivot Pharma to Enter into Licensing Agreement with Solmic Research 12
Equity Offering 13
Pivot Pharma Raises USD1.2 Million in Private Placement of Units 13
Pivot Pharma Raises USD0.3 Million in Private Placement of Shares 14
Debt Offering 15
Pivot Pharma Raises USD4 Million in Private Placement of 10% Debentures 15
Acquisition 16
Pivot Pharma Acquires Thrudermic 16
Pivot Pharma Acquires IndUS Pharma 17
Pivot Pharmaceuticals Inc – Key Competitors 18
Pivot Pharmaceuticals Inc – Key Employees 19
Pivot Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Sep 07, 2018: Pivot Pharmaceuticals names Dr. Joseph Borovsky as Board Chairman 21
Nov 20, 2017: Pivot Pharmaceuticals Receives Conditional Approval for CSE Listing 22
Other Significant Developments 23
May 15, 2018: Pivot Provides Shareholder Update 23
Apr 04, 2018: Pivot Pharmaceuticals Provides Product Development Update 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Tables
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pivot Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Pivot Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pivot Pharma to Acquire BiPhasix Transdermal Drug Delivery Technology from Altum Pharma 11
Pivot Pharma to Enter into Licensing Agreement with Solmic Research 12
Pivot Pharma Raises USD1.2 Million in Private Placement of Units 13
Pivot Pharma Raises USD0.3 Million in Private Placement of Shares 14
Pivot Pharma Raises USD4 Million in Private Placement of 10% Debentures 15
Pivot Pharma Acquires Thrudermic 16
Pivot Pharma Acquires IndUS Pharma 17
Pivot Pharmaceuticals Inc, Key Competitors 18
Pivot Pharmaceuticals Inc, Key Employees 19
Pivot Pharmaceuticals Inc, Other Locations 20
Pivot Pharmaceuticals Inc, Subsidiaries 20
List of Figures
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pivot Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9